Mohan, V and John, Mary and Goswami, S and Magdam, M and Kant, S and Vimal, MV and Amarnath, S (2019) Precision Medicine with Sulfonylureas: From Clinical Studies to Bedside Practice. Journal of the Association of Physicians, 67 . p. 27.
Precision medicine is part of personalized therapy that is based on an individual’s genetic/epigenetic imprints, lifestyle, and environmental characteristics. Recent advances in understanding of the genomic landscape in diabetes mellitus have identified genetic polymorphisms associated with the risk of diabetes mellitus along with other related complications such as cardiovascular risk or hypoglycemia, in turn, spurring the development of precision medicine in prevention and management of diabetes mellitus. Here we will discuss the various genetic polymorphisms that are currently being explored for the development of precision medicine with sulfonylureas, such as glimepiride, for management of people with diabetes.
|Divisions:||Department of Diabetology|
|Deposited By:||surendar radha|
|Deposited On:||05 Feb 2020 14:25|
|Last Modified:||05 Feb 2020 14:25|
Repository Staff Only: item control page